Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday-March 2024-www.financetom.com

Market

Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday

Aug 7, 2024 6:30 AM

09:11 AM EDT, 08/07/2024 (MT Newswires) -- Health care stocks were leaning higher premarket Wednesday, with the Health Care Select Sector SPDR Fund ( XLV ) up 0.4% and the iShares Biotechnology ETF ( IBB ) unchanged.

Veracyte ( VCYT ) shares rose 20% after the company reported higher results for Q2 and increased its sales forecast range for 2024.

Zai Lab ( ZLAB ) shares climbed 11% after it posted a narrower loss in Q2.

Novo Nordisk ( NVO ) reported higher results for Q2 and cut its outlook for 2024 operating profit growth to a range of 20% to 28% at constant exchange rates, from 22% to 30% previously. Shares of the company declined 5% pre-bell.

Previous page： Next page： Sector Update: Tech

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

08:50 AM EDT, 06/17/2025 (MT Newswires) -- Technology stocks were declining premarket Tuesday with the Technology Select Sector SPDR Fund (XLK) down 0.4% and the SPDR S&P Semiconductor ETF (XSD) 0.1% lower recently. Jabil ( JBL ) shares were up more than 3% after the company reported higher fiscal Q3 diluted core earnings and revenue and raised its fiscal 2025...

Sector Update: Health Care

Jun 17, 2025

08:55 AM EDT, 06/17/2025 (MT Newswires) -- Health care stocks were steady premarket Tuesday as the Health Care Select Sector SPDR Fund (XLV) was marginally lower and the iShares Biotechnology ETF (IBB) was inactive recently. Eli Lilly ( LLY ) said it has agreed to acquire Verve Therapeutics ( VERV ) for up to $1.3 billion to advance gene-editing therapies...

COLUMN-Foreign central banks are shrinking U.S. asset exposure: McGeever

Jun 17, 2025

(The opinions expressed here are those of the author, a columnist for Reuters.) By Jamie McGeever ORLANDO, Florida, June 17 (Reuters) - As debate rages around 'de-dollarization' and the world's appetite for dollar-denominated assets, one major cohort of overseas investors appears to be quietly backing away from U.S. securities: central banks. That's the conclusion to be drawn from the New...